For adjuvant radiation decision making purposes, how is the "Lower Uterine Segment" (LUS) defined?

We have always used the pathologist's description of LUS (fundus, body, LUS, and cervix). That being said, I don’t use LUS as risk factor for deciding adjuvant treatment except in borderline cases where may lean towards brachytherapy if otherwise a candidate for observation.